SCHEMBL30702002

SCHEMBL30702002

Cn1c(=O)n(COCC[Si](C)(C)C)c2cncc(N)c21

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27191846 1.00 NPC1 (0.36) NPC1MAPT
SCHEMBL27191727 0.85 NPC1 (0.34) NPC1MAPT
SCHEMBL30702016 0.85 NPC1 (0.34) NPC1MAPT
SCHEMBL24195939 0.74 NPC1 (0.38) NPC1
SCHEMBL26925003 0.74 NPC1 (0.38) NPC1MAPT
SCHEMBL24196230 0.74 NPC1 (0.38) NPC1
SCHEMBL31211967 0.73 NPC1 (0.48) NPC1
SCHEMBL29502401 0.72 NPC1 (0.41) NPC1MAPT
SCHEMBL31276238 0.72 NPC1 (0.43) NPC1MAPT
SCHEMBL13015496 0.72 NPC1 (0.41) NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565574-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2025-06-11 — — EP disclosed
CN-119731159-A SARS-CoV2 main proteinase inhibitor 吉利德科学公司 2025-03-28 — — CN disclosed
WO-2024031089-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2024-02-08 — — WO disclosed
Send feedback